sellWeak10b5-1 plan
Zachary B. Fleming sold $660 of SMTI
Chief Executive Officer at Sanara MedTech Inc.. 20 shares at an average of $33.02, traded Nov 2, 2022, filed Nov 4, 2022.
Warning score
5Value
$660
20 shares
Holdings after
37,250
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$660 at market
- 0Share of holdings soldSold 0.1% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001493152-22-030674, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 2, 2022 | SOpen-market sale Common Stock10b5-1 | -20 | $33.02 | $660 | 37,250 | Nov 4, 2022 |
Related signals
Other insiders at Sanara MedTech Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | Sanara MedTech Inc. | Zachary B. Fleming Chief Executive Officer | $14k 417 shares | -1% | |
| 5Weak | Sanara MedTech Inc. | Zachary B. Fleming Chief Executive Officer | $19k 563 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.